Financial Distress in Patients With Advanced Cancer (DIFIC)

Civil Hospices of Lyon

Status: Completed

Conditions: Quality of Life; Cancer

Treatments: Other: self-completion questionnaire

Study type: Interventional

Funder types: Other

Identifiers

NCT01868100

2012.762

Details and patient eligibility

About

Advanced cancer has an adverse effect in virtually all dimensions of patients' lives (physical, psychosocial, spiritual, familial, role function). One of the less frequently explored effects of cancer is its impact on personal finances and the contribution of financial-related distress to overall suffering and quality of life. Financial issues have been recently found to be the second most frequent source of distress identified by cancer patients in a community cancer center context (22%).

In the context of continuous increased health care costs, it is likely that the frequency of health care related financial problems will keep rising. The relative contribution of these adverse financial events in advanced cancer patients to overall patient distress is not well assessed and this is particularly true in France. The main objective of this work is to determine the association between financial distress and quality of life of patients with advanced cancer in a Public General Hospital and in a Comprehensive Cancer Center. A secondary objective is to characterize the frequency and intensity of financial distress reported by French cancer patients and their impact on their quality of life.

Enrollment: 144 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients must be at least 18 years old and have a diagnosis of advanced cancer which is defined as one of the following: recurrent disease, received >2 lines of chemotherapy, locally-advanced disease, metastatic disease, or refractory disease.
• Patients must have a cancer diagnosis of: breast, colon, lung or prostate.
• Patients must be able to understand, read, write, and speak French.

Exclusion criteria

• Clinical evidence of cognitive impairment, as determined by the palliative care physician.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

144 participants in 1 patient group

self-completion questionnaire

No Intervention group

Treatment:

Other: self-completion questionnaire